Published in Physician Law Weekly, September 19th, 2007
This trend article about Mayo Clinic is an immediate alert from NewsRx to identify developing directions of research.
Study 1: In this recent article published in the journal Gynecologic Oncology, scientists in the United States conducted a study "To characterize the molecular pathways involved in apoptosis following administration of histone deacetylase inhibitors to Type I and II endometrial cancer cells. Ark2, Ishikawa, and AN3 cell lines representing both Type I and II endometrial cancers were treated with various concentrations of oxamflatin and HDAC inhibitor-L Cell apoptosis was...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Physician Law Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.